Fuente: Labiotech Lugar: News and Trends The EU Biotech Act is expected to reduce clinical trial timelines, boost biomanufacturing, and most importantly, attract investments.
The post “It’s time to Act”: EU biotech to undergo major changes  appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.